NURS 6521 Week 9 Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders
NURS 6051 Transforming Nursing and Healthcare Through Technology – Step-by-Step Guide
The first step before starting to write the NURS 6051 Transforming Nursing and Healthcare Through Technology, it is essential to understand the requirements of the assignment. The first step is to read the assignment prompt carefully to identify the topic, the length and format requirements. You should go through the rubric provided so that you can understand what is needed to score the maximum points for each part of the assignment.
It is also important to identify the audience of the paper and its purpose so that it can help you determine the tone and style to use throughout. You can then create a timeline to help you complete each stage of the paper, such as conducting research, writing the paper, and revising it to avoid last-minute stress before the deadline. After identifying the formatting style to be applied to the paper, such as APA, you should review its use, such as writing citations and referencing the resources used. You should also review how to format the title page and the headings in the paper.
How to Research and Prepare for NURS 6051 Transforming Nursing and Healthcare Through Technology
The next step in preparing for your paper is to conduct research and identify the best sources to use to support your arguments. Identify the list of keywords from your topic using different combinations. The first step is to visit the university library and search through its database using the important keywords related to your topic. You can also find books, peer-reviewed articles, and credible sources for your topic from PubMed, JSTOR, ScienceDirect, SpringerLink, and Google Scholar. Ensure that you select the references that have been published in the last words and go through each to check for credibility. Ensure that you obtain the references in the required format, for example, in APA, so that you can save time when creating the final reference list.
You can also group the references according to their themes that align with the outline of the paper. Go through each reference for its content and summarize the key concepts, arguments and findings for each source. You can write down your reflections on how each reference connects to the topic you are researching about. After the above steps, you can develop a strong thesis that is clear, concise and arguable. Next you should create a detailed outline of the paper so that it can help you to create headings and subheadings to be used in the paper. Ensure that you plan what point will go into each paragraph.
How to Write the Introduction for NURS 6051 Transforming Nursing and Healthcare Through Technology
The introduction of the paper is the most crucial part as it helps to provide the context of your work, and will determine if the reader will be interested to read through to the end. You should start with a hook, which will help capture the reader’s attention. You should contextualize the topic by offering the reader a concise overview of the topic you are writing about so that they may understand its importance. You should state what you aim to achieve with the paper. The last part of the introduction should be your thesis statement, which provides the main argument of the paper.
How to Write the Body for NURS 6051 Transforming Nursing and Healthcare Through Technology
The body of the paper helps you to present your arguments and evidence to support your claims. You can use headings and subheadings developed in the paper’s outline to guide you on how to organize the body. Start each paragraph with a topic sentence to help the reader know what point you will be discussing in that paragraph. Support your claims using the evidence conducted from the research, ensure that you cite each source properly using in-text citations. You should analyze the evidence presented and explain its significance and how it connects to the thesis statement. You should maintain a logical flow between each paragraph by using transition words and a flow of ideas.
How to Write the In-text Citations for NURS 6051 Transforming Nursing and Healthcare Through Technology
In-text citations help the reader to give credit to the authors of the references they have used in their works. All ideas that have been borrowed from references, any statistics and direct quotes must be referenced properly. The name and date of publication of the paper should be included when writing an in-text citation. For example, in APA, after stating the information, you can put an in-text citation after the end of the sentence, such as (Smith, 2021). If you are quoting directly from a source, include the page number in the citation, for example (Smith, 2021, p. 15). Remember to also include a corresponding reference list at the end of your paper that provides full details of each source cited in your text. An example paragraph highlighting the use of in-text citations is as below:
The integration of technology in nursing practice has significantly transformed patient care and improved health outcomes. According to Smith (2021), the use of electronic health records (EHRs) has streamlined communication among healthcare providers, allowing for more coordinated and efficient care delivery. Furthermore, Johnson and Brown (2020) highlight that telehealth services have expanded access to care, particularly for patients in rural areas, thereby reducing barriers to treatment.
How to Write the Conclusion for NURS 6051 Transforming Nursing and Healthcare Through Technology
When writing the conclusion of the paper, start by restarting your thesis, which helps remind the reader what your paper is about. Summarize the key points of the paper, by restating them. Discuss the implications of your findings and your arguments. End with a call to action that leaves a lasting impact on the reader or recommendations.
How to Format the Reference List for NURS 6051 Transforming Nursing and Healthcare Through Technology
The reference helps provide the reader with the complete details of the sources you cited in the paper. The reference list should start with the title “References” on a new page. It should be aligned center and bolded. The references should be organized in an ascending order alphabetically and each should have a hanging indent. If a source has no author, it should be alphabetized by the title of the work, ignoring any initial articles such as “A,” “An,” or “The.” If you have multiple works by the same author, list them in chronological order, starting with the earliest publication.
Each reference entry should include specific elements depending on the type of source. For books, include the author’s last name, first initial, publication year in parentheses, the title of the book in italics, the edition (if applicable), and the publisher’s name. For journal articles, include the author’s last name, first initial, publication year in parentheses, the title of the article (not italicized), the title of the journal in italics, the volume number in italics, the issue number in parentheses (if applicable), and the page range of the article. For online sources, include the DOI (Digital Object Identifier) or the URL at the end of the reference. An example reference list is as follows:
References
Johnson, L. M., & Brown, R. T. (2020). The role of telehealth in improving patient outcomes. Journal of Nursing Care Quality, 35(2), 123-130. https://doi.org/10.1097/NCQ.0000000000000456
Smith, J. A. (2021). The impact of technology on nursing practice. Health Press.
NURS 6521 Week 9 Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders Instructions
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?
For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.
To Prepare:
Review the Resources for this module and reflect on the different health needs and body systems presented.
Your Instructor will assign you a complex case study to focus on for this Discussion.
Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.
Post a brief description of your patient’s health needs from the patient case study you assigned.
Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why.
Be sure to justify your response.
Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples. Have a look at NURS 6521 Week 11 Assignment: Off-Label Drug Use in Pediatrics
Your discussion post should include a brief description of your patient’s health needs, referencing the case study provided.
You will then explain the type of treatment regimen you would recommend for your patient, including an explanation why (be sure to justify your response).
You will then include a patient education strategy for assisting your patient with the management of their health needs, being specific and providing examples.
Women’s and Men’s Health, Infections, and Hematologic Systems.
CASE STUDY 2
A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago.
NURS 6521 Week 9 Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders Example
The patient in this case study is a 46-year-old woman with a family history of breast cancer and has been up to date on yearly mammograms. She is currently having hot flashes, nocturnal sweats, and genitourinary issues. She had been feeling good up until a month ago when she went to see her gynecologist for her yearly exam and to talk about her symptoms.
Her Pap smear has been routine except for a history of ASCUS around five years ago. She has a history of hypertension (HTN) and is currently taking Norvasc 10mg once a day and HCTZ 25mg once daily. The patient’s blood pressure is 150/90 today. She has regular monthly menstrual cycles, with her last menstrual period (LMP) occurring one month ago.
The patient presents with conventional signs of perimenopause, the transitional phase preceding menopause, including hot flushes, nocturnal sweats, and genitourinary problems. Regular menstrual cycles do not rule out perimenopause, as cycles can remain regular early (Nik Hazlina et al., 2022). The symptoms and age of the patient are consistent with this diagnosis. The patient’s heightened blood pressure may be a consequence of the hormonal fluctuations that occur during perimenopause, or it may be a recurrence of the pre-existing hypertension.
Managing perimenopausal symptoms while reducing risks related to a family history of breast cancer and pre-existing hypertension are among the patient’s primary concerns. To prevent cardiovascular problems, the caregiver should also strive for optimal blood pressure regulation.
Treatment Recommendation and Justification
Hormone replacement therapy (HRT) should be considered as part of the treatment regimen to address perimenopausal symptoms (Langer et al., 2021). For the treatment of vasomotor symptoms such as hot flashes and night sweats, doctors may prescribe estrogen therapy alone or in conjunction with progestin. Given that the patient has hypertension, careful thought should be given to the hormone therapy option (Palacios et al., 2019). In this situation, transdermal estrogen might be considered as it may affect blood pressure less than oral estrogen.
Given the patient’s current blood pressure measurement of 150/90, modifying or reevaluating the antihypertensive drugs, Norvasc and HCTZ, may be necessary to regulate blood pressure better. Achieving blood pressure objectives and lowering the risk of cardiovascular problems may require adding more antihypertensive drugs or modifying the current prescriptions (Khalil & Zeltser, 2023). In addition, the patient ought to think about modifying their lifestyle. To improve perimenopausal symptoms and blood pressure regulation, it is recommended to lose weight, reduce sodium in the diet, exercise regularly, and manage stress.
Patient Education
Patient education is crucial for managing the patient’s health needs. The patient should be advised of hormone replacement treatment’s potential benefits and hazards (Langer et al., 2021). Emphasizing lifestyle changes, such as a nutritious diet, frequent exercise, and stress reduction, can also improve overall health and aid in managing hypertension. The patient should be educated on the significance of regular follow-up appointments to monitor blood pressure, evaluate drug efficacy, and address any concerns or adverse effects (Khalil & Zeltser, 2023).
It is also critical to talk about breast cancer screening and preventative techniques because the patient has a family history of the disease (Budh & Sapra, 2023). Encourage the patient to continue having annual mammograms and to self-examine their breasts frequently. Education on recognizing the signs and symptoms of breast cancer and the importance of early detection should be part of the patient education plan.
References
Budh, D. P., & Sapra, A. (2023). Breast Cancer Screening. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556050/
Khalil, H., & Zeltser, R. (2023). Antihypertensive Medications. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554579/
Langer, R. D., Hodis, H. N., Lobo, R. A., & Allison, M. A. (2021). Hormone replacement therapy – where are we now? Climacteric: The Journal of the International Menopause Society, 24(1), 3–10. https://doi.org/10.1080/13697137.2020.1851183
Nik Hazlina, N. H., Norhayati, M. N., Shaiful Bahari, I., & Nik Muhammad Arif, N. A. (2022). Prevalence of psychosomatic and genitourinary syndrome among menopausal women: A systematic review and meta-analysis. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.848202
Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M., & Graziottin, A. (2019). Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Women’s Health (London, England), 15, 174550651986400. https://doi.org/10.1177/1745506519864009
NURS 6521 Week 9 Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders Example 2
Case Study 1
HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday (day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting.
Ht: 5’8” Wt: 89 kg
Allergies: Penicillin (rash)
Community-Acquired Pneumonia Case Study
Community-acquired pneumonia (CAP) is a subtype not acquired in a hospital or clinical setting. It may be caused by bacteria, viruses, and fungi, especially in immunocompromised patients. Despite the availability of a wide range of antibiotics and other treatment options, pneumonia remains a highly infectious disease with high morbidity and mortality. Therapeutic regimens need to be well developed and tailored towards specific patient needs and thorough patient education extended to the patients.
HH, a 68-year-old male, is admitted to the hospital and diagnosed with community-acquired pneumonia. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He is on empiric antibiotics, including ceftriaxone 1 g IV day (day 3) and azithromycin 500 mg IV day (day 3). His clinical status has improved since admission; however, he complains of nausea and vomiting and is not tolerating a diet. He is allergic to penicillin.
Treatment Regimen
Various treatment options exist for the management of CAP. However, fluoroquinolone monotherapy is preferred due to its relative safety, efficacy, and reduced association with antimicrobial resistance. Fluoroquinolones (levofloxacin and moxifloxacin) inhibit bacterial DNA synthesis by inhibiting the topoisomerase enzyme function. They are generally safe and well-tolerated and are considered the first-line option for patients with comorbidities (Karampela, 2020).
Fluoroquinolones have excellent oral bioavailability with extensive tissue penetration and have an elimination half-life of six to 12 hours, thus allowing once-daily dosing and ensuring compliance. They undergo extensive hepatic metabolism and renal excretion, thus being recommended for use in patients with normal hepatic and renal function. They have fewer adverse effects than other antibiotics, including nausea, vomiting, and photosensitivity, with the rare occurrence of tendinitis (Rosenthal, 2021). Blood glucose levels should be closely monitored as fluoroquinolones have a hypoglycemic effect.
Patient Education Strategy
The teach-back method is a useful strategy for promoting patient education. The care provider may explain to the patient the need to minimize physical contact with friends and family and maintain proper hygiene by regular handwashing or using alcohol-based sanitizers. They may also be taught to practice pursed-lip and diaphragmatic breathing to control dyspnea (Liu, 2019). The care provider then asks the patient to reiterate this information in their own words to assess their level of understanding.
The goal of treatment is to reduce the global disease burden by disease prevention, curbing antimicrobial resistance, and ensuring patient safety. Physicians need to optimize treatment regimens by tailoring them towards specific patient needs, depending on their age and comorbidities.
References
Karampela, I., & Dalamaga, M. (2020). Could respiratory fluoroquinolones, levofloxacin, and moxifloxacin prove to be beneficial as an adjunct treatment in COVID-19? Archives of Medical Research, 51(7), 741–742. https://doi.org/10.1016/j.arcmed.2020.06.004
Liu, S., Tong, X., Ma, Y., Wang, D., Huang, J., Zhang, L., Wu, M., Wang, L., Liu, T., & Fan, H. (2019, April 17). Respiratory fluoroquinolones monotherapy vs. β-lactams with or without macrolides for hospitalized community-acquired pneumonia patients: A meta-analysis. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00489
Rosenthal, L. D., Burchum, J. R., & Lehne, R. A. (2021). In Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.). Elsevier.
